Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

5:00 PM ET Form 4
Insider Selling Smartfinancial Inc. SMBK

Smartfinancial Director Steven B. Tucker Sells $173K of Stock

Steven B. Tucker, Director, sold 3,500 shares of Smartfinancial Inc. at $49.50 a share, worth $173K in total on Oct 23, 2026. Shares held after the trade: 47,222 (-6.9%).

Value
$173K
Shares
3,500
Price
$49.50
Role
Director
Holding change
-6.9%
Trade date
Oct 23, 2026
4:57 PM ET 8-K
Nasdaq/NYSE Compliance Notice Zeo Energy Corp. ZEO

Zeo Energy Nasdaq/NYSE Compliance Notice

Zeo Energy Corp. received a 180-day extension from Nasdaq, until April 19, 2027, to regain compliance with the $1.00 minimum bid price requirement. The company's Class A common stock will continue to trade on the Nasdaq Capital Market during this period while management monitors the stock price and considers options to meet the listing standard.

Counterparty
Nasdaq
Term
180 days
4:55 PM ET 8-K
Capital Raise Lycia Therapeutics, Inc. LYCA

Lycia Therapeutics Capital Raise

Lycia Therapeutics, Inc. filed its Amended and Restated Certificate of Incorporation and Bylaws in connection with the closing of its initial public offering. These governance changes were previously approved by the board and stockholders to take effect upon the IPO's completion.

4:55 PM ET 8-K
Financial Results Nucor Corp NUE

Nucor Financial Results

Nucor Corporation reported Q3 2026 net earnings of $1.32 billion on net sales of $11.25 billion, driven by strong demand and higher average selling prices in its steel mills segment. The company generated $2.7 billion in free cash flow year-to-date and achieved operational milestones including the first heat at its West Virginia sheet mill.

Term
Q3 2026

“I want to thank our teammates for delivering another strong quarter and making 2026 the safest summer in Nucor history. Supported by robust demand across key end markets, Nucor has generated approximately $2.7 billion of free cash flow and returned nearly $1.4 billion to shareholders through the first nine months of the year.”

Leon Topalian, Nucor’s Chair and Chief Executive Officer

“We also achieved important milestones in advancing our growth strategy, including the first heat at our West Virginia sheet mill in September and the recent start-up of our second galvanizing line at Nucor Steel Berkeley. These projects, together with other recent investments, are expanding Nucor’s capabilities and strengthening our position in attractive markets.”

Leon Topalian, Nucor’s Chair and Chief Executive Officer
4:54 PM ET 10-Q
Financial Results Bank of Hawaii Corp BOH

Bank of Hawaii Q3 2026 Results: Net Income $64.3M, Up 20.5% YoY

Bank of Hawaii reported net income of $64.3 million for the third quarter of 2026, an increase from $53.3 million in the same period of 2025. Total assets decreased slightly to $23.8 billion as of September 30, 2026, compared to $24.2 billion at year-end 2025, primarily driven by a reduction in cash and cash equivalents and held-to-maturity investment securities.

Key figure
Net income $64.3M · +20.5% YoY
4:53 PM ET 8-K
M&A Deal Rallybio Corp RLYB

Rallybio Signs $82.7M M&A Deal with Avenzo Therapeutics, Inc.

Rallybio Corporation provided a status update on its pending merger with Avenzo Therapeutics, declaring a special cash distribution of approximately $82.7 million ($13.56 per share) to stockholders. The distribution is based on the company's estimated net cash exceeding zero prior to the merger closing and is scheduled for payment on November 13, 2026.

Value
$82.7M
Counterparty
Avenzo Therapeutics, Inc.
4:53 PM ET 8-K
Capital Raise Apollo Asset Backed Credit Co LLC

Apollo Asset Backed Credit Co Capital Raise of $34.7M

Apollo Asset Backed Credit Company LLC issued and sold unregistered shares across multiple classes for total aggregate consideration of approximately $34.73 million as of October 1, 2026. The company also disclosed its Transactional Net Asset Value (NAV) per share as of September 30, 2026, which serves as the pricing basis for ongoing sales and its quarterly share repurchase program.

Value
$34.7M
4:52 PM ET Form 4
Insider Buying Alpha Cognition Inc. ACOG

Alpha Cognition Insider Opaleye Management Inc. Buys $266K of Stock

Opaleye Management Inc. bought 32,090 shares of Alpha Cognition Inc. at $8.23 to $8.33 a share (average $8.28) in 2 transactions, worth $266K in total between Oct 22, 2026 and Oct 23, 2026. Shares held after the trade: 3,291,984 (+0.5%).

Value
$266K
Shares
32,090
Average price
$8.28
Holding change
+0.5%
Trade date
Oct 22, 2026 to Oct 23, 2026
4:51 PM ET Form 4
Insider Selling Charles River Laboratories International, Inc. CRL

Charles River Laboratories International Insider James C. Foster Sells $8.41M of Stock

James C. Foster sold 24,042 shares of Charles River Laboratories International, Inc. at $350.00 a share, worth $8.41M in total on Oct 22, 2026. Shares held after the trade: 31,596 (-43.2%).

Value
$8.41M
Shares
24,042
Price
$350.00
Holding change
-43.2%
Trade date
Oct 22, 2026
4:51 PM ET Form 4
Insider Buying Boundless Bio, Inc. BOLD

Boundless Bio 10% Owner Kevin Tang Buys $51.6K of Stock

Kevin Tang, 10% Owner, bought 21,640 shares of Boundless Bio, Inc. at $2.38 to $2.40 a share (average $2.39) in 3 transactions, worth $51.6K in total between Oct 22, 2026 and Oct 26, 2026. Shares held after the trade: 3,011,749 (+0.3%).

Value
$51.6K
Shares
21,640
Average price
$2.39
Role
10% Owner
Holding change
+0.3%
Trade date
Oct 22, 2026 to Oct 26, 2026
4:50 PM ET 8-K
Leadership Change Standex International Corp SXI

Standex International Leadership Change

Standex International Corporation appointed Brenna D. Preisser as a Class I director, effective January 1, 2027, succeeding the retiring B. Joanne Edwards. Ms. Preisser, currently an Executive Vice President at Brunswick Corporation, will receive a $150,000 restricted stock award and standard non-employee director compensation.

4:50 PM ET 8-K
Other 8-K Filing Genvor Inc GNVR

Genvor Other 8-K Filing

Genvor Incorporated entered into an Intellectual Property Assignment Agreement with its founder and Chief Scientific Officer, Dr. Jesse Jaynes. Dr. Jaynes assigned the rights to approximately 9,000 synthetic antimicrobial peptide sequences and associated validation data to the company for use in its research and commercialization programs.

Counterparty
Dr. Jesse Jaynes
4:48 PM ET 8-K
Leadership Change Soren Acquisition Corp. SORN

Soren Acquisition Leadership Change

Soren Acquisition Corp. implemented a planned leadership transition, appointing Joseph Tonnos as Chief Financial Officer and a director, succeeding Jamie Weber. Additionally, Roger Cloutier Jr. and Austin Criden were appointed to the board following the resignations of Spencer Gerrol and Charles N. Kahn III. These changes are part of a broader alignment with the Di Rezze Family Office, which sponsors the SPAC.

4:47 PM ET 8-K
Clinical Trial Data Mirum Pharmaceuticals, Inc. MIRM

Mirum Pharmaceuticals Clinical Trial Data

Mirum Pharmaceuticals announced positive results from Cohort 2 of its pivotal PROGRESS study evaluating ATEBRIOZ (zilurgisertib) in pediatric patients aged 6 to <12 with fibrodysplasia ossificans progressiva (FOP). The study met its endpoints with a significant reduction in total heterotopic ossification lesion volume and improved joint mobility compared to placebo, supporting a planned sNDA submission in the first half of 2027.

4:46 PM ET 8-K
Court & Legal Update Kinetik Holdings Inc. KNTK

Kinetik Holdings Court & Legal Update

Kinetik Holdings subsidiary EagleClaw Midstream Ventures reached a settlement with Energy Transfer to resolve a dispute regarding the expiration date of an NGL purchase agreement. The parties confirmed the agreement will terminate on December 31, 2026, while a second agreement remains subject to ongoing litigation awaiting adjudication.

Counterparty
Energy Transfer GC NGL Product Services, LLC
Term
through Dec 2026
4:45 PM ET 8-K
Clinical Trial Data Longeveron Inc. LGVN

Longeveron Clinical Trial Data

Longeveron announced updated Phase 2b ELPIS II trial results for laromestrocel in infants with hypoplastic left heart syndrome (HLHS). While the trial missed its primary efficacy endpoint of RVEF change, additional analysis showed the secondary endpoint of major adverse cardiac events (MACE) achieved statistical significance with only 1 event in the treatment arm versus 8 in the standard of care arm (P=0.043).

Counterparty
National Institutes of Health (NIH)
4:43 PM ET Form 4
Insider Buying Capital City Bank Group Inc CCBG

Capital City Bank Group Director William F. Butler Buys $20K of Stock

William F. Butler, Director, bought 392 shares of Capital City Bank Group Inc at $51.07 a share, worth $20K in total on Oct 26, 2026. Shares held after the trade: 7,137 (+5.8%).

Value
$20K
Shares
392
Price
$51.07
Role
Director
Holding change
+5.8%
Trade date
Oct 26, 2026
4:42 PM ET 8-K
Financial Results Flexsteel Industries Inc FLXS

Flexsteel Industries Financial Results

Flexsteel Industries reported fiscal first quarter 2027 net sales of $114.0 million, a 3.2% increase year-over-year, driven by 5.1% growth in Flexsteel branded products. GAAP net income per diluted share was $1.24, down from $1.31 in the prior year quarter, impacted by foreign currency headwinds and rising ocean transportation and material costs.

Term
Q1 2027

“I'm pleased with our first quarter results and the continued momentum of our growth strategies despite a challenging macroeconomic environment. Net sales increased 3.2 percent compared to the prior year, toward the upper end of our guidance range, marking our twelfth consecutive quarter of year-over-year growth.”

Derek Schmidt, CEO of Flexsteel Industries, Inc.

“From a profitability standpoint, we delivered a GAAP operating margin of approximately 6 percent, which included a $0.8 million or 70 bps unfavorable foreign currency translation impact related to our peso-denominated asset exposure in Mexico.”

Derek Schmidt, CEO of Flexsteel Industries, Inc.
4:42 PM ET 8-K/A
Business Update Graftech International Ltd EAF

Graftech International Business Update

GrafTech International Ltd. finalized estimates for its previously announced permanent closure of its manufacturing facility in Monterrey, Mexico. The company expects to incur total non-cash charges of $25 million to $35 million, including $12.3 million in fixed asset write-offs, while maintaining its estimate of $20 million to $25 million in one-time cash expenditures.

4:42 PM ET 8-K
Deal Termination Supernus Pharmaceuticals, Inc. SUPN

Supernus Pharmaceuticals Deal Termination with UBS Bank USA

Supernus Pharmaceuticals terminated its uncommitted demand revolving credit line with UBS Bank USA on October 20, 2026. The termination was made in anticipation of the company's pending merger with Indivior Pharmaceuticals and the establishment of a new senior secured credit facility for the combined entity. There were no outstanding borrowings or early termination penalties associated with the cancellation.

Counterparty
UBS Bank USA
4:42 PM ET 8-K
Dividend Columbus Mckinnon Corp CMCO

Columbus Mckinnon Dividend

Columbus McKinnon Corporation's Board of Directors declared a regular quarterly cash dividend of $0.07 per common share. The dividend is payable on November 16, 2026, to shareholders of record as of November 6, 2026.

4:42 PM ET 8-K
Court & Legal Update CV Sciences, Inc. CVSI

CV Sciences Court & Legal Update

CV Sciences has settled an arbitration case initiated in February 2025 against its former legal counsel. Under the settlement terms, the company received $500,000 and both parties have mutually released all claims against each other.

Counterparty
former legal counsel
4:41 PM ET 8-K
Clinical Trial Data Cumberland Pharmaceuticals Inc CPIX

Cumberland Pharmaceuticals Clinical Trial Data

Cumberland Pharmaceuticals announced plans to submit a New Drug Application (NDA) for ifetroban to treat cardiomyopathy associated with Duchenne muscular dystrophy (DMD). The submission is supported by Phase 2 FIGHT DMD trial data showing a statistically significant 5.4% improvement in left ventricular ejection fraction (LVEF) compared to a control group. While the FDA expressed concerns regarding the sufficiency of the data package for efficacy requirements, the company is moving forward with the submission following a pre-NDA meeting.

Counterparty
FDA
4:40 PM ET 8-K
Leadership Change Praetorian Acquisition Corp. PTOR

Praetorian Acquisition Leadership Change

Praetorian Acquisition Corp. implemented a planned leadership transition, appointing Joseph Tonnos as Chief Financial Officer and a director, succeeding Peter Ondishin. The company also appointed Roger L. Cloutier, Jimmy Vaiopoulos, and Charles P. Garcia to its board of directors following the resignations of Nicole Seligman, Erica Dorfman, and Alex Elias.

4:40 PM ET 8-K
Dividend Bain Capital Private Credit

Bain Capital Private Credit Dividend

Bain Capital Private Credit declared a regular monthly distribution of $0.1875 per Class I share for shareholders of record as of October 30, 2026. The filing also disclosed a net asset value (NAV) per share of $26.03 as of September 30, 2026, and the sale of $57.0 million in unregistered shares to feeder vehicles.

4:40 PM ET 8-K
M&A Deal Weave Communications, Inc. WEAV

Weave Communications Signs $650M M&A Deal with Francisco Partners

Weave Communications, Inc. completed its acquisition by Francisco Partners in an all-cash transaction valued at approximately $650 million. Under the terms of the deal, Weave stockholders received $7.40 per share, and the company has transitioned to a privately held entity, delisting from the New York Stock Exchange.

Value
$650M
Counterparty
Francisco Partners

“Today marks the start of an exciting new chapter for Weave. For nearly two decades, Weave has built solutions for independent practices caring for patients in communities across the country. Today, more than 40,000 locations rely on us to deepen their relationship with patients through automated communication and engagement solutions. With Francisco Partners’ support and resources, we’re well positioned to deliver even more value to the practices we serve. I want to thank our employees, whose dedication made this milestone possible.”

Brett White, Chief Executive Officer of Weave

“Weave sits at the center of how tens of thousands of healthcare practices communicate with their patients and collect revenue. We are pleased to officially partner with Brett and the Weave team and see significant opportunity to build on that position through continued product innovation in AI-powered patient engagement and payments solutions.”

Ezra Perlman, Co-President at Francisco Partners
4:37 PM ET Form 4
Insider Selling Atlantic Union Bankshares Corp AUB

Atlantic Union Bankshares EVP Matthew L. Linderman Sells $310K of Stock

Matthew L. Linderman, EVP, sold 7,746 shares of Atlantic Union Bankshares Corp at $40.00 a share, worth $310K in total on Oct 22, 2026. Shares held after the trade: 10,455 (-42.6%).

Value
$310K
Shares
7,746
Price
$40.00
Role
EVP
Holding change
-42.6%
Trade date
Oct 22, 2026
4:37 PM ET 8-K
Financial Results Firstsun Capital Bancorp FSUN

Firstsun Capital Bancorp Financial Results

FirstSun Capital Bancorp reported Q3 2026 net income of $38.4 million, or $0.82 per diluted share, reflecting improved net interest margins and operating synergies from its recent acquisition of First Foundation. The company also completed a core system conversion for First Foundation and repurchased $49.7 million of its own common stock during the quarter.

Term
Q3 2026

“Third quarter results reflect our continued progress on our strategic priorities highlighted by an improved net interest margin as a result of continued balance sheet improvements, a strong diversified revenue profile and improved earnings performance, including benefits from operating synergies realized following the acquisition of First Foundation in the second quarter.”

Neal Arnold, FirstSun’s Chief Executive Officer and President

“Additionally, in late September, we successfully completed the core system conversion of First Foundation, representing another important milestone in our overall integration plan. I'm extremely proud of our teammates for all the hard work, planning and collaboration in completing the conversion while continuing to serve our great clients throughout the process.”

Neal Arnold, FirstSun’s Chief Executive Officer and President
4:37 PM ET 8-K
Leadership Change TrueBlue, Inc. TBI

TrueBlue Leadership Change

TrueBlue, Inc. has appointed Elizabeth Castro Gulacsy to its Board of Directors and its Audit Committee, effective October 26, 2026. Ms. Castro Gulacsy, the former CFO of United Parks & Resorts, joins as an independent director as part of a board refreshment process and a previously disclosed cooperation agreement with EHS Management. Her appointment increases the total number of directors on the TrueBlue board to ten.

4:36 PM ET 8-K
Dividend HPS Corporate Lending Fund

HPS Corporate Lending Fund Dividend

HPS Corporate Lending Fund declared regular and variable supplemental distributions for October 2026 across all share classes, payable to shareholders of record as of October 31, 2026. The total net distribution for Class I shares is $0.1990 per share, with payments expected on or about November 30, 2026. The Fund also reported a net asset value (NAV) of $24.45 per share for all classes as of September 30, 2026.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.